181 related articles for article (PubMed ID: 30158472)
1. Development and Evaluation of a Reconstitutable Dry Suspension to Improve the Dissolution and Oral Absorption of Poorly Water-Soluble Celecoxib.
Kim HI; Park SY; Park SJ; Lee J; Cho KH; Jee JP; Kim HC; Maeng HJ; Jang DJ
Pharmaceutics; 2018 Aug; 10(3):. PubMed ID: 30158472
[TBL] [Abstract][Full Text] [Related]
2. Mechanism of dissolution enhancement and bioavailability of poorly water soluble celecoxib by preparing stable amorphous nanoparticles.
Liu Y; Sun C; Hao Y; Jiang T; Zheng L; Wang S
J Pharm Pharm Sci; 2010; 13(4):589-606. PubMed ID: 21486533
[TBL] [Abstract][Full Text] [Related]
3. Preparation and Characterization of Celecoxib Nanosuspension Using Bead Milling.
Kim HI; Jee JP; Kim ST; Kang D; Kim YC; Kim HC; Park SY; Lee HM; Cho KH; Kim DY; Choi SU; Jang DJ
J Nanosci Nanotechnol; 2019 Feb; 19(2):1184-1187. PubMed ID: 30360230
[TBL] [Abstract][Full Text] [Related]
4. Optimization of Hydroxypropyl Methylcellulose and Dextrin in Development of Dried Nanosuspension for Poorly Water-Soluble Drug.
Heo EJ; Park SY; Kim HI; Sung JH; Kwon HJ; Jee JP; Maeng HJ; Cho KH; Kim ST; Kim YC; Choi SU; Jang DJ
J Nanosci Nanotechnol; 2020 Sep; 20(9):5813-5818. PubMed ID: 32331187
[TBL] [Abstract][Full Text] [Related]
5. Development and Evaluation of Poorly Water-Soluble Celecoxib as Solid Dispersions Containing Nonionic Surfactants Using Fluidized-Bed Granulation.
Kwon HJ; Heo EJ; Kim YH; Kim S; Hwang YH; Byun JM; Cheon SH; Park SY; Kim DY; Cho KH; Maeng HJ; Jang DJ
Pharmaceutics; 2019 Mar; 11(3):. PubMed ID: 30897776
[TBL] [Abstract][Full Text] [Related]
6. Celecoxib Nanoformulations with Enhanced Solubility, Dissolution Rate, and Oral Bioavailability: Experimental Approaches over In Vitro/In Vivo Evaluation.
Arslan A; Yet B; Nemutlu E; Akdağ Çaylı Y; Eroğlu H; Öner L
Pharmaceutics; 2023 Jan; 15(2):. PubMed ID: 36839685
[TBL] [Abstract][Full Text] [Related]
7. Preparation and evaluation of celecoxib-loaded proliposomes with high lipid content.
Jeon D; Kim KT; Baek MJ; Kim DH; Lee JY; Kim DD
Eur J Pharm Biopharm; 2019 Aug; 141():139-148. PubMed ID: 31150807
[TBL] [Abstract][Full Text] [Related]
8. In Vitro and In Vivo Evaluation of Core-Shell Mesoporous Silica as a Promising Water-Insoluble Drug Delivery System: Improving the Dissolution Rate and Bioavailability of Celecoxib With Needle-Like Crystallinity.
Han C; Zhang S; Huang H; Dong Y; Sui X; Jian B; Zhu W
J Pharm Sci; 2019 Oct; 108(10):3225-3232. PubMed ID: 31226426
[TBL] [Abstract][Full Text] [Related]
9. Development of a novel celecoxib-loaded nanosuspension using a wet media milling process.
Jeong SC; Kim DS; Jin SG; Youn YS; Oh KT; Li DX; Yong CS; Oh Kim J; Kim KS; Choi HG
Pharmazie; 2018 Sep; 73(9):498-502. PubMed ID: 30223931
[TBL] [Abstract][Full Text] [Related]
10. Preparation and Evaluation of Eudragit L100-PEG Proliponiosomes for Enhanced Oral Delivery of Celecoxib.
Kim MH; Kim DH; Nguyen DT; Lee HS; Kang NW; Baek MJ; An J; Yoo SY; Mun YH; Lee W; Kim KT; Cho CW; Lee JY; Kim DD
Pharmaceutics; 2020 Jul; 12(8):. PubMed ID: 32751591
[TBL] [Abstract][Full Text] [Related]
11. Cefdinir nanosuspension for improved oral bioavailability by media milling technique: formulation, characterization and in vitro-in vivo evaluations.
Sawant KK; Patel MH; Patel K
Drug Dev Ind Pharm; 2016; 42(5):758-68. PubMed ID: 26548349
[TBL] [Abstract][Full Text] [Related]
12. A quality-by-design study to develop Nifedipine nanosuspension: examining the relative impact of formulation variables, wet media milling process parameters and excipient variability on drug product quality attributes.
Patel PJ; Gajera BY; Dave RH
Drug Dev Ind Pharm; 2018 Dec; 44(12):1942-1952. PubMed ID: 30027778
[TBL] [Abstract][Full Text] [Related]
13. Solubility enhancement of BCS Class II drug by solid phospholipid dispersions: Spray drying versus freeze-drying.
Fong SY; Ibisogly A; Bauer-Brandl A
Int J Pharm; 2015 Dec; 496(2):382-91. PubMed ID: 26468038
[TBL] [Abstract][Full Text] [Related]
14. In vitro/in vivo evaluation of felodipine micropowders prepared by the wet-milling process combined with different solidification methods.
Meng J; Li S; Yao Q; Zhang L; Weng Y; Cai C; Xu H; Tang X
Drug Dev Ind Pharm; 2014 Jul; 40(7):929-36. PubMed ID: 23614872
[TBL] [Abstract][Full Text] [Related]
15. Spray drying of a poorly water-soluble drug nanosuspension for tablet preparation: formulation and process optimization with bioavailability evaluation.
Sun W; Ni R; Zhang X; Li LC; Mao S
Drug Dev Ind Pharm; 2015 Jun; 41(6):927-33. PubMed ID: 24785575
[TBL] [Abstract][Full Text] [Related]
16. Study on the dissolution improvement of albendazole using reconstitutable dry nanosuspension formulation.
Fülöp V; Jakab G; Bozó T; Tóth B; Endrésik D; Balogh E; Kellermayer M; Antal I
Eur J Pharm Sci; 2018 Oct; 123():70-78. PubMed ID: 30010031
[TBL] [Abstract][Full Text] [Related]
17. Comparing various techniques to produce micro/nanoparticles for enhancing the dissolution of celecoxib containing PVP.
Homayouni A; Sadeghi F; Varshosaz J; Garekani HA; Nokhodchi A
Eur J Pharm Biopharm; 2014 Sep; 88(1):261-74. PubMed ID: 24952357
[TBL] [Abstract][Full Text] [Related]
18. Improved oral bioavailability of core-shell structured beads by redispersion of the shell-forming nanoparticles: preparation, characterization and in vivo studies.
Yao Q; Tao X; Tian B; Tang Y; Shao Y; Kou L; Gou J; Li X; Yin T; Tang X
Colloids Surf B Biointerfaces; 2014 Jan; 113():92-100. PubMed ID: 24060933
[TBL] [Abstract][Full Text] [Related]
19. Design of self-dispersible dry nanosuspension through wet milling and spray freeze-drying for poorly water-soluble drugs.
Niwa T; Danjo K
Eur J Pharm Sci; 2013 Nov; 50(3-4):272-81. PubMed ID: 23907001
[TBL] [Abstract][Full Text] [Related]
20. Formulation, optimization and in vitro-in vivo evaluation of febuxostat nanosuspension.
Ahuja BK; Jena SK; Paidi SK; Bagri S; Suresh S
Int J Pharm; 2015 Jan; 478(2):540-52. PubMed ID: 25490182
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
